KY Biotechnology & Medical Research

Adagene Inc (ADAG)

Track

Adagene Inc. witnessed two buy transactions totaling approximately $84,764 over the past ninety days. Chief Executive Officer Peter Luo executed these purchases, representing the sole insider activity during this period. The stock price increased by 9.1% recently, currently trading at the 68th percentile of its annual range without any pending earnings report scheduled.
Ticker: ADAG Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Luo Peter Chief Executive Officer Executive Director
Transaction date
Purchase
Price
48.94
Quantity 71,510 +46.2%
Value US$2,783,543
Luo Peter Chief Executive Officer Executive Director
Transaction date
Purchase
Price
150.71
Quantity 42,498 -24.0%
Value US$2,668,894
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-05 B Purchase
Luo Peter

Chief Executive Officer

Executive Director
71,510 +46.2%
48.94
US$2,783,543 		71,510 +46.2% 48.94 US$2,783,543
2026-08-06 2026-08-04 B Purchase
Luo Peter

Chief Executive Officer

Executive Director
42,498 -24.0%
150.71
US$2,668,894 		42,498 -24.0% 150.71 US$2,668,894
Explore more

More insider trading research around Adagene Inc

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity